BMY vs BRT · P/E 17, rev $24.46B vs rev $49.1M
Bristol-Myers Squibb Company (BMY) versus BRT Realty Trust (BRT) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
BRT Realty Trust (BRT) is a reit - residential company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported BRT revenue for 2026-06-30 was $49.1M. Net income was -$5.9M. Revenue was up 99.5% from 2026-03-31 to 2026-06-30. BRT currently screens at market cap $275.6M.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. BRT currently screens at market cap $275.6M.
Not investment advice. Open the BMY and BRT stock pages for the full models.
Not investment advice.